Поисковый запрос: (<.>S=РЕЖИМЫ ВВЕДЕНИЯ<.>) |
Общее количество найденных документов : 92
Показаны документы с 1 по 20
|
|
1.
| Survival of irradiated mice treated with WR-151327, synthetic trehalose dicorynomycolate, or ofloxacin // Adv. Space Res., 1994. Vol. 14, N 10.-С.583-586
|
2.
| Hainsworth John D. Paclitaxel administered by 1-Hour infusion: Preliminary results of a phase I/II trial comparing two schedules // Cancer, 1994. Vol. 74, N 4.-С.1377-1382
|
3.
| Treatment of experimental schistosoma mansoni with praziquantel alone and combined with cimetidine // Arzneim.-Forsch., 1994. Vol. 44, N 11.-С.1268-1270
|
4.
| Treatment of experimental schistosoma mansoni with praziquantel alone and combined with cimetidine // Arzneim.-Forsch., 1994. Vol. 44, N 11.-С.1268-1270
|
5.
| Long-term GH regulation by different patterns of GHRH administration // J. Physiol. Proc., 1996, N 493.-С.121S
|
6.
| Protective effects of two different oestrogen treatments on the bone loss of ovariectomized rats // J. Physiol. Proc., 1996, N 493.-С.137S-138S
|
7.
| Tacrolimus (FK506) and methotrexate regimens to prevent graftversus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation // Bone Marrow Transplant., 1996. Vol. 17, N 4.-С.649-653
|
8.
| Tacrolimus (FK506) and methotrexate regimens to prevent graftversus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation // Bone Marrow Transplant., 1996. Vol. 17, N 4.-С.649-653
|
9.
| Protective effects of two different oestrogen treatments on the bone loss of ovariectomized rats // J. Physiol. Proc., 1996, N 493.-С.137S-138S
|
10.
| Tacrolimus (FK506) and methotrexate regimens to prevent graftversus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation // Bone Marrow Transplant., 1996. Vol. 17, N 4.-С.649-653
|
11.
| Long-term GH regulation by different patterns of GHRH administration // J. Physiol. Proc., 1996, N 493.-С.121S
|
12.
| Protective effects of two different oestrogen treatments on the bone loss of ovariectomized rats // J. Physiol. Proc., 1996, N 493.-С.137S-138S
|
13.
| Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: A comparison of three dosing regimens // Biopharm. and Drug Dispos., 1998. Vol. 19, N 1.-С.31-38
|
14.
| Pharmacokinetics and pharmacodynamics of recombinant tissue-type plasminogen activator following intravenous administration in rabbits: A comparison of three dosing regimens // Biopharm. and Drug Dispos., 1998. Vol. 19, N 1.-С.31-38
|
15.
| Mоделювання фармакокiнетики пролiкiв та iх метаболiтiв 2: Нелiнiйнi моделi оптимiзацii режимiв введення пролiкiв // Клiн. фармацiя, 1999. Vol. 3, N 1.-С.85-90, 141
|
16.
| Insulin administration // Diabetes Care, 2001. Vol. 24, прил. N 1.-С.94-97
|
17.
| Insulin administration // Diabetes Care, 2001. Vol. 24, прил. N 1.-С.94-97
|
18.
| Petry Nancy M. Examining the limits of the buprenorphine interdosing interval: Daily, every-third-day and every-fifth-day dosing regimens // Addiction, 2001. Vol. 96, N 6.-С.823-834
|
19.
| Канов Е.В. Фармакокинетика галодифа при различной продолжительности его введения // Эксперим. и клин. фармакол., 2002. Т. 65, N 2.-С.56-58
|
20.
| Subcutaneous epoetin-alpha every one, two, and three weeks in renal anemia // J. Nephrol., 2002. Vol. 15, N 5.-С.565-574
|
|
|
|
Главная
Назад
"Электронные каталоги и базы данных библиотек СО РАН"